OOIR: Observatory of International Research

Papers

(The TQCC of American Journal of Drug and Alcohol Abuse is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population	57
Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies	51
Assessment of liability to substance use disorder induced by two emerging stimulants, 4,4′-dimethylaminorex and escaline, in mice	38
Differential effects of moderate chronic ethanol consumption on neurobehavior, white matter glial protein expression, and mTOR pathway signaling with adolescent brain maturation	31
A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorder	25
Initial evidence of reliability and validity of an implicit association test assessing attitudes toward individuals who use substances	24
Assessing factors associated with knowledge of Driving Under the Influence (DUI) penalties	22
Willingness to provide a hair sample for drug testing: results from an anonymous multi-city intercept survey	21
Dopamine D2/D3 receptor availability and working memory in stimulant use disorder	20
Opioid overdose after extended-release buprenorphine injection: a case report	19
Alcohol-related non-fatal motor vehicle crash injury in the US from 2019 to 2022	19
Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone	19
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial	18
In utero chronic cannabis exposure is associated with lower total brain volume in the first month of postnatal life	18
Addressing stimulant use disorder through state opioid response grants from the substance abuse and mental health services administration: Missouri’s initial approach	17
Many leveled ordinal models for frequency of alcohol and drug use	17
Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies	17
The alcohol use disorders identification test (AUDIT): factor structure, test-retest reliability and longitudinal measurement invariance across a one-year interval in an Australian sample	16
Association of drinking behaviors with TXNIP DNA methylation levels in leukocytes among the general Japanese population	15
Rapid microinduction of buprenorphine/naloxone for opioid use disorder in a large safety net hospital: a retrospective case series	15
Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products	14
Internet-based, continuously available Narcotics Anonymous meetings: a new resource for access to Twelve Step support for abstinence	14
Disentangling the effects of racism-related stress on opioid use disorder and chronic pain outcomes	14
A novel rural hospital/clinic-system practice-based research network: the Rural Addiction Implementation Network (RAIN) initiative and its goals, implementation, and early results	13
Withdrawal interference scale: a novel measure of withdrawal-related life disruption in opioid use disorder and alcohol use disorder	13

Social influence on drug use and sexual behaviors among rural LGBTQ+ individuals	12
Development and initial findings from the Peer Recovery Coach (PRC) checklist: a new tool to assess the nature of peer recovery coaching service delivery	12
Psychometric evaluation of a person-centered opioid and opioid problems perception questionnaire (PC-OOPPQ)	12
Geographic trends in overall and long-acting opioid prescriptions under Medicaid and Medicare Part D in the United States, 2013–2021	12
Plasma concentrations of the inflammatory adipokine lipocalin-2 are not affected by chronic alcohol exposure in rats or acute alcohol administration in people with alcohol use disorder	12
Assessment of patient perception of treatment assignment and patient-reported outcomes in a cannabis use disorder trial	12
Functional neuroanatomy of craving in heroin use disorder: voxel-based meta-analysis of functional magnetic resonance imaging (fMRI) drug cue reactivity studies	12
Alcohol protective behavioral strategies for young adults: a content analysis across drinking contexts and gender	11
The cost-effectiveness of long-term post-treatment peer recovery support services in the United States	11
Alterations in surface-based brain morphometry in men with opioid use disorder	11
X-ray absorption spectroscopy combined with deep learning for auto and rapid illicit drug detection	10
Cocaine self-administration behavior is associated with subcortical and cortical morphometry measures in individuals with cocaine use disorder	10
Flexibly modeling age trends in the prevalence of co-occurring patterns of substance use and mental health disorders using time-varying effects and latent class analysis	10
Plasma leptin levels are lower in females, but not males, with ketamine use disorder	10
Changes in frequency of cannabis use among people with HIV during the COVID-19 pandemic: a multi-methods study to explore the underlying reasons for change	10
Gene knockdown of HCN2 ion channels in the ventral tegmental area reduces ethanol consumption in alcohol preferring rats	10
Changes in attitudes toward alcohol control policies in Lithuania: findings from two representative surveys in 2015 and 2020	10
Anger is more strongly associated with alcohol and tobacco use and use disorders compared to other substances in American adults	10
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use	10
Age patterns and predictors of cannabis initiation among biracial and monoracial U.S. youth	9
Psychometric properties of the Spanish Simultaneous Alcohol and Cannabis Motives Measure (S-SMM) and its short form (S-SMM-SF) among young adults	9
Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder	9
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study	9
Large-scale longitudinal analysis of the progression of alcohol use among members of a social media platform: an observational study	9
Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia	9
Coroner county systems are associated with a higher likelihood of unclassified drug overdoses compared to medical examiner county systems	9
Overdoses and deaths related to the use of ketamine and its analogues: a systematic review	9
Strategies to address co-occurring behavioral health needs among justice-involved youth	9
How much illegally manufactured fentanyl could the U.S. be consuming?	9
Differential prevalence of Adverse Childhood Experiences (ACEs) by gender and substance used in individuals with cannabis, cocaine, opioid, and tobacco use disorders	9
Cannabis retail store density and county-level mortality from injury in the state of Washington from 2009–2020	8
Assessment of the Short Grit Scale in patients with substance use disorder: Psychometric properties and patient characteristics	8
Six-month length of stay associated with better recovery outcomes among residents of sober living houses	8
A study of long-term supraphysiologic-dose anabolic-androgenic steroid use on cognitive function in middle-aged men	8
Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity	8
Alterations in self-reported sensory gating and interoception in individuals frequently using cannabis	7
Effects of fisetin on ethanol-induced rewarding properties in mice	7
Meta-analysis of primary care delivered buprenorphine treatment retention outcomes	7
Childhood trauma, intraindividual reaction time variability, baseline respiratory sinus arrhythmia, and perceived relapse tendency among males with substance use disorders	7
Exploring prescription opioid misuse among college students: a secondary analysis of ACHA National College Health Assessment data (2019–2022)	7
Synergistic effect of combined transcranial direct current stimulation and Matrix ‎Model on the reduction of methamphetamine craving and improvement of cognitive ‎functioning: a randomized sham-contro	6
Alcohol use and drinking motives across five countries: a post-COVID-19 pandemic update	6
The global distribution and epidemiology of alcohol and drug use among street-involved children and youth: a meta-analysis	6
Benefits of Alcoholics Anonymous affiliation among meeting attendees in Romania: a mixed methods approach	6
Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids	6
Improving Spanish translations of tobacco dependence measures using cognitive interviewing	6
Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County	6
Alcohol withdrawal and amphetamine co-use in an animal model for attention deficit hyperactivity disorder	6
A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse	6
Telehealth for opioid use disorder: retention as a function of demographics and rurality	6

Fiduciary assignment as a potential intervention for substance use disorder: a retrospective chart review	6
Buprenorphine in safety-sensitive positions	6